Importance of Cervical Screening for Women Above 35

Cervical cancer remains one of the leading causes of cancer-related deaths among women worldwide. Early detection through cervical screening can significantly reduce mortality and improve outcomes. Women above 35 are at an increased risk, making timely screening crucial for identifying precancerous changes and ensuring prompt intervention.

Understanding the Cervical Anatomy and SCJ

The squamocolumnar junction (SCJ) is a critical area on the cervix where the squamous and columnar epithelium meet. At puberty, the SCJ is located closer to the vaginal opening, but with age, it gradually moves into the endocervical canal. This dynamic movement creates the transformation zone (TZ), the region most susceptible to HPV-induced carcinogenesis.

Proper visualization of the SCJ during screening is essential. However, studies show that even women aged 35–44 can have partially hidden SCJs, affecting the accuracy of visual cervical examinations.

Why Screening is Essential for Women Over 35

Screening women above 35 helps detect abnormal cellular changes before they progress into cervical cancer. Common screening methods include:

• Pap smear tests
• HPV DNA tests
• Co-testing (Pap + HPV)

Early detection enables timely treatment and prevents progression to invasive cancer. Even subtle changes in the SCJ and TZ can be detected by experienced gynecologists during routine screenings.

Factors Affecting Cervical Screening Accuracy

Several factors can influence the effectiveness of cervical screening in women above 35:

• SCJ Visibility: Incomplete visualization of the transformation zone may require specialized evaluation or endocervical sampling.
• Age-Related Changes: Hormonal fluctuations and menopause can affect cervical anatomy.
• High-Risk HPV Infection: Persistent HPV infection increases the risk of cervical cancer.

Advanced evaluation techniques, including histopathology and targeted excision procedures, are recommended when SCJ visualization is limited.

Role of Gynecologists and Specialists

An experienced gynecologist ensures accurate screening, identifies high-risk patients, and provides timely intervention. Dr. Aprajita Srivastava, a highly skilled gynecologist, IVF specialist, and laparoscopic surgeon based in Sector 121, Noida, is known for her expertise in reproductive medicine, infertility treatments, and advanced procedures like IVF, IUI, and egg freezing. She specializes in addressing complex fertility and high-risk pregnancy cases.

Women concerned about cervical health or planning pregnancies can consult with a best gynecologist in Noida or explore infertility specialist in Noida services for personalized care.

Guidelines for Cervical Screening

Most international guidelines recommend cervical screening for women aged 30–65, with continued screening until age 65 depending on risk factors and previous results. High-quality screening programs prioritize:

• Regular Pap smears every 3 years
• HPV testing every 5 years
• Co-testing every 5 years

Early intervention based on screening results reduces cervical cancer incidence and ensures better reproductive outcomes for women over 35.

Conclusion

Cervical screening is a vital preventive measure for women above 35. Timely detection of abnormal cells, combined with expert evaluation by specialists like Dr. Aprajita Srivastava, increases the chances of preventing cervical cancer and maintaining reproductive health. Women are encouraged to schedule regular screenings and follow expert advice for optimal care.

For more guidance on fertility planning and preparation, refer to prepare for IVF treatment for women considering assisted reproductive options alongside cervical health monitoring.